Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open Label Phase 2 Pilot Trial of Subjects With Complex Non-healing Diabetic Foot Ulcers Treated With Standard Care Plus Cryopreserved Umbilical Cord Allograft (TTAX01)

NCT03230175 is registered in ClinicalTrials.gov with BioTissue Holdings, Inc as lead sponsor.

NCT NCT03230175
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03230175 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open Label Phase 2 Pilot Trial of Subjects With Complex Non-healing Diabetic Foot Ulcers Treated With Standard Care Plus Cryopreserved Umbilical Cord Allograft (TTAX01)
Lead sponsor
BioTissue Holdings, Inc
Phase
Phase 2
Overall status
Completed
Start date
October 4, 2017
Completion date
April 1, 2019
Enrollment
32 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot infection, non-healing diabetic foot ulcer, non-healing wound